1306262662

1306262662 was paid $2.37M by Medicaid between Jan 2018 and Mar 2020, across 177 billing codes. Its largest line is 80050, General health panel — 7.3% of everything it billed.

33Billing provider info1306262662

33aNPI1306262662

33bProvider type—

28Total paid$2.37M

24GClaims368,395

24DCodes billed177

24AFirst – last monthJan 2018 – Mar 2020

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	155,720	$1.17M
2019	196,911	$1.12M
2020	15,764	$80K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
80050	General health panel	7.3%	7,319	6,627	$172K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	4.8%	3,476	2,753	$113K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	4.4%	7,466	6,499	$105K
80061	Lipid panel	4.3%	19,616	17,463	$103K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	4.3%	4,570	3,862	$102K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	4.2%	4,537	3,843	$101K
80053	Comprehensive metabolic panel	2.6%	17,987	16,202	$62K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	2.6%	25,431	22,066	$62K
84443	Thyroid stimulating hormone (TSH)	2.6%	13,582	12,314	$61K
83036	Hemoglobin; glycosylated (A1C)	2.4%	15,952	13,986	$56K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	2.3%	3,768	3,275	$53K
80373		2.1%	3,779	3,262	$50K

165 more codes

80372		2.1%	3,703	$49K
80369		1.6%	2,669	$39K
82607		1.6%	4,893	$37K
80074		1.5%	2,136	$36K
80348		1.5%	3,912	$36K
86696		1.5%	2,543	$35K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	1.5%	1,937	$35K
80362		1.5%	3,721	$35K
80346		1.5%	3,489	$34K
80354		1.5%	3,726	$34K
80358		1.4%	3,749	$33K
80361		1.3%	3,175	$30K
80365		1.3%	3,181	$30K
80356		1.2%	3,032	$29K
80324		1.2%	3,417	$29K
84439		1.2%	6,595	$28K
80349		1.2%	2,910	$28K
80335		1.1%	2,777	$27K
87086	Culture, bacterial; quantitative colony count, urine	1.1%	16,267	$27K
83992		1.1%	3,159	$27K
80367		1.1%	1,837	$27K
80355		1.1%	2,736	$27K
80353		1.1%	3,088	$26K
80359		1.0%	2,782	$24K
80368		<1%	1,659	$23K
80366		<1%	1,650	$23K
86695		<1%	2,546	$22K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	691	$19K
80048	Basic metabolic panel (calcium, ionized)	<1%	8,026	$18K
87077		<1%	10,450	$18K
80345		<1%	2,707	$18K
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	<1%	273	$17K
80321		<1%	1,836	$17K
82746		<1%	2,234	$16K
80360		<1%	1,661	$16K
87186		<1%	10,448	$15K
82728		<1%	2,329	$14K
84403		<1%	909	$13K
80076		<1%	3,508	$13K
84481		<1%	2,024	$13K
80305		<1%	1,879	$12K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	434	$12K
86592		<1%	4,289	$11K
83550		<1%	2,519	$10K
86038		<1%	1,363	$10K
36415	Collection of venous blood by venipuncture	<1%	10,126	$9K
83970		<1%	391	$9K
86803		<1%	1,183	$9K
82553		<1%	1,120	$8K
83880		<1%	950	$8K
83540		<1%	2,913	$8K
84484		<1%	1,032	$7K
84144		<1%	524	$7K
84152		<1%	742	$6K
81001		<1%	4,815	$6K
84702		<1%	804	$6K
80164		<1%	1,581	$6K
82550		<1%	1,455	$6K
86431		<1%	1,535	$6K
84153		<1%	1,095	$6K
86140		<1%	2,182	$5K
83735		<1%	2,038	$5K
84436		<1%	3,416	$4K
86677		<1%	702	$4K
84154		<1%	447	$4K
83001		<1%	319	$4K
84270		<1%	296	$4K
83002		<1%	304	$4K
84402		<1%	258	$4K
87070		<1%	1,833	$3K
82043		<1%	1,510	$3K
83525		<1%	549	$3K
84479		<1%	2,819	$3K
85652		<1%	2,539	$3K
83690		<1%	774	$3K
87799		<1%	360	$3K
86141		<1%	400	$3K
84550		<1%	1,229	$2K
82150		<1%	676	$2K
86317		<1%	242	$2K
84703		<1%	436	$2K
87340		<1%	479	$2K
87481		<1%	321	$2K
80185		<1%	446	$2K
81015		<1%	3,074	$2K
87512		<1%	55	$2K
85610		<1%	2,088	$2K
83721		<1%	5,108	$2K
87653		<1%	220	$2K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	220	$2K
82951		<1%	227	$2K
80156		<1%	516	$2K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	137	$1K
87640		<1%	229	$1K
86376		<1%	126	$1K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	241	$1K
82677		<1%	88	$1K
82570		<1%	1,770	$1K
84466		<1%	188	$1K
86708		<1%	190	$1K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	125	$1K
87040		<1%	360	$1K
87529		<1%	145	$1K
85027		<1%	324	$1K
87556		<1%	149	$1K
82947		<1%	476	$1K
84460		<1%	273	$996.03
85730		<1%	536	$987.61
82272		<1%	756	$965.06
82670		<1%	44	$939.43
84146		<1%	107	$923.43
87496		<1%	153	$921.36
85379		<1%	184	$888.74
87500		<1%	79	$881.70
82533		<1%	82	$853.59
87081		<1%	221	$824.44
82105		<1%	91	$756.26
87641		<1%	119	$747.69
86336		<1%	88	$736.92
84450		<1%	174	$709.00
84311		<1%	1,288	$681.15
85007		<1%	3,781	$657.64
86704		<1%	99	$632.00
87324		<1%	204	$524.77
84163		<1%	51	$462.92
86762		<1%	100	$457.31
87592		<1%	16	$447.72
82542		<1%	241	$408.72
84480		<1%	303	$403.03
83021		<1%	61	$396.43
87210		<1%	116	$366.04
81003		<1%	1,028	$359.19
82652		<1%	16	$332.27
85018		<1%	646	$311.26
85014		<1%	643	$305.36
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	19	$291.22
80069		<1%	111	$286.50
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	38	$279.75
80320		<1%	25	$253.26
84134		<1%	119	$207.85
83986		<1%	1,315	$203.73
87205		<1%	280	$181.49
87650		<1%	31	$173.56
83789		<1%	49	$156.98
87150		<1%	86	$155.99
84600		<1%	15	$152.04
84132		<1%	434	$149.42
87147		<1%	62	$148.64
82248		<1%	61	$143.62
86850		<1%	78	$140.77
86800		<1%	14	$126.72
80184		<1%	53	$125.51
86901		<1%	80	$77.87
86900		<1%	78	$71.38
82977		<1%	18	$60.88
82950		<1%	19	$57.42
81025		<1%	19	$47.26
85045		<1%	18	$37.91
84100		<1%	14	$33.11
85041		<1%	125	$32.01
81000		<1%	372	$16.41
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	0%	28	$0.00
80323		0%	17	$0.00
86480		0%	19	$0.00
G0103	Prostate cancer screening; prostate specific antigen test (psa)	0%	49	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.